Englewood, CO, United States of America

Gregory Thomas Everson

USPTO Granted Patents = 16 

 

 

Average Co-Inventor Count = 1.6

ph-index = 5

Forward Citations = 82(Granted Patents)


Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: Gregory Thomas Everson: Innovating Hepatic Function Assessment

Introduction

Gregory Thomas Everson, based in Englewood, Colorado, is a distinguished inventor with a remarkable portfolio of 14 patents. His innovative contributions primarily focus on the assessment and treatment of chronic liver diseases, showcasing his commitment to advancing medical science and patient care.

Latest Patents

Among his latest inventions is a groundbreaking method for assessing hepatic function and portal blood flow. This method presents a simplified, in vitro test, known as the STAT test, which estimates portal blood flow from a single blood sample collected 60 minutes after administering deuterated-cholate. This test is particularly valuable for patients suspected of having Chronic Hepatitis C, Primary Sclerosing Cholangitis (PSC), Non-Alcoholic Fatty Liver Disease (NAFLD), or any chronic liver ailment.

Additionally, Everson has developed methods for monitoring the treatment of chronic liver diseases. His Disease Severity Index (DSI) utilizes non-invasive liver function test results to assess the progression of liver conditions. The DSI aids in predicting clinical outcomes, response to antiviral treatment, and disease progression. Furthermore, Everson's research also focuses on non-invasive diagnostic methods categorizing PSC patients into Slow Progressors, Moderate Progressors, and Rapid Progressors, thereby refining treatment strategies.

Career Highlights

Gregory Thomas Everson's professional journey is marked by his role at the University of Colorado, where he works on pioneering research in hepatic function evaluation and chronic liver disease management. His expertise and dedication have made significant impacts in the fields of hepatology and patient care.

Collaborations

Throughout his career, Everson has collaborated with esteemed professionals in the field, including Steve Mark Helmke and Michael Anthony Martucci. Their combined expertise underscores the collaborative nature of medical innovation and research, harnessing diverse insights to advance understanding and treatment of liver diseases.

Conclusion

Gregory Thomas Everson stands out as a key innovator in the field of medical science, particularly in the realm of chronic liver disease assessment and treatment. His patents and collaborative efforts have not only enhanced diagnostic methodologies but have also improved patient outcomes, reflecting his commitment to innovation and excellence in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…